FUSION PHARMACEUTICALS INC - COM (FUSN)

CUSIP: 36118A100

Q3 2021 13F Holders as of 30 Sep 2021

Type / Class
Equity / COM
Total 13F shares
27,852,055
Share change
+369,004
Total reported value
$220,616,238
Price per share
$7.92
Number of holders
39
Value change
+$2,907,083
Number of buys
17
Number of sells
12

Quarterly Holders Quick Answers

What is CUSIP 36118A100?
CUSIP 36118A100 identifies FUSN - FUSION PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of FUSION PHARMACEUTICALS INC - COM (FUSN) as of Q3 2021

As of 30 Sep 2021, FUSION PHARMACEUTICALS INC - COM (FUSN) was held by 39 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 27,852,055 shares. The largest 10 holders included JOHNSON & JOHNSON, FMR LLC, ORBIMED ADVISORS LLC, CANADA PENSION PLAN INVESTMENT BOARD, ADAMS STREET PARTNERS LLC, TPG Group Holdings (SBS) Advisors, Inc., Pivotal bioVenture Partners Investment Advisor LLC, FEDERATED HERMES, INC., PERCEPTIVE ADVISORS LLC, and Rock Springs Capital Management LP. This page lists 39 institutional shareholders reporting positions in this security for the Q3 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.